Imagine a future where parents can choose their baby's traits. In-vitro gametogenesis (IVG) is making this closer to reality ...

This PhD thesis addresses the urgent need for better therapies by developing advanced in vitro models and engineered heart tissues to better simulate human heart physiology and pathology. Through the ...

Understanding how cells transform into specialized types during human development is a central challenge in biology. This ...

Understanding how cells transform into specialized types during human development is a central challenge in biology. This ...

At the Third International Summit on Human Genome Editing, held in March 2023 at the Francis Crick Institute in London, ...

In our weekly column, Quick Bites, we round up the latest developments in the alt-protein and sustainable food industry.

Creative Medical Technology (CELZ) announced an expanded agreement with Greenstone Biosciences to leverage Artificial Intelligence in further ...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical”), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced an expanded agreement ...

Cynata Therapeutics (ASX:CYP) has had its induced pluripotent stem cell (iPSC) derived mesenchymal stem cell (MSCs) verified ...

SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived ...

Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug Administration ...